PharVision Advisers’s Granite Construction GVA Stock Holding History

PharVision Advisers’s Portfolio GVA Stock Details GVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,854	Closed	-$313K	–	817
2025 Q3	$313K	Buy	+2,854	New	+$293K	0.18%	204

Other funds holding GVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

HCC

Hill City Capital Boston, Massachusetts $2.8B AUM 79.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's GVA Position: Q4 2025 in Review

PharVision Advisers sold out of Granite Construction (GVA) in Q4 2025, closing a stake of 2,854 shares — an estimated $313K sold.

PharVision Advisers first reported a position in GVA in Q3 2025 and held it in 1 quarter. The position peaked at $313K in Q3 2025. 393 funds tracked by Wall St. Rank hold GVA as of Q4 2025.

PharVision Advisers reported no remaining Granite Construction position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 2,854 Granite Construction shares in Q4 2025, an estimated $313K.
PharVision Advisers first reported a position in Granite Construction in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Granite Construction position peaked at $313K in Q3 2025.
393 funds tracked by Wall St. Rank held Granite Construction as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.